In contrast to the observations of Prasse et al. [88], CCL18 was not found to have value in predicting IPF progression in another study, and no significant difference in baseline concentration of CCL18 between progressors and nonprogressors was found [87]. Here, CCL18 is linked to idiopathic pulmonary fibrosis.